Intravenous Tirofiban Versus Thrombolysis Before Mechanical Thrombectomy in Stroke
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1014 participants.
Also called NCT05728333
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 1,014 participants
- Registry
-
NCT05728333
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05728333. Randomized; double masking; primary purpose treatment. Start 2023-11-28 (actual); primary completion 2026-05-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous Tirofiban Versus Thrombolysis Before Mechanical Thrombectomy in Stroke
- Acronym
- ADJUVANT
- Condition
- Stroke, Acute Ischemic
- Intervention (Drug)
- Tirofiban
- Intervention (Drug)
- Thrombolysis
- Lead sponsor
- Xinqiao Hospital of Chongqing
- Collaborator
- Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine
Record details
- Record id
cardio:ct-nct05728333- Content hash
9e6daa6c7a1b6e907d5039339075a087f7617fb3978c46ee37df0cadc0a9f422